Report Detail
Global Monoclonal Antibodies Market Professional Survey Report 2019
- RnM3735802 |
- 10 September, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The global Monoclonal Antibodies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Monoclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Monoclonal Antibodies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Monoclonal Antibodies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Monoclonal Antibodies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
Segment by Application
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology
Table of Contents
Executive Summary
1 Industry Overview of Monoclonal Antibodies
- 1.1 Definition of Monoclonal Antibodies
- 1.2 Monoclonal Antibodies Segment by Type
- 1.2.1 Global Monoclonal Antibodies Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Cancer
- 1.2.3 Autoimmune Diseases
- 1.2.4 Infection
- 1.2.5 Hematological Diseases
- 1.2.6 Others
- 1.3 Monoclonal Antibodies Segment by Applications
- 1.3.1 Global Monoclonal Antibodies Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oncology
- 1.3.3 Autoimmune and inflammatory diseases
- 1.3.4 Respiratory diseases
- 1.3.5 Ophthalmology
- 1.4 Global Monoclonal Antibodies Overall Market
- 1.4.1 Global Monoclonal Antibodies Revenue (2014-2025)
- 1.4.2 Global Monoclonal Antibodies Production (2014-2025)
- 1.4.3 North America Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.4 Europe Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.5 China Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.6 Japan Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.8 India Monoclonal Antibodies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Monoclonal Antibodies
- 2.3 Manufacturing Process Analysis of Monoclonal Antibodies
- 2.4 Industry Chain Structure of Monoclonal Antibodies
3 Development and Manufacturing Plants Analysis of Monoclonal Antibodies
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Monoclonal Antibodies Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Monoclonal Antibodies
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Monoclonal Antibodies Production and Capacity Analysis
- 4.2 Monoclonal Antibodies Revenue Analysis
- 4.3 Monoclonal Antibodies Price Analysis
- 4.4 Market Concentration Degree
5 Monoclonal Antibodies Regional Market Analysis
- 5.1 Monoclonal Antibodies Production by Regions
- 5.1.1 Global Monoclonal Antibodies Production by Regions
- 5.1.2 Global Monoclonal Antibodies Revenue by Regions
- 5.2 Monoclonal Antibodies Consumption by Regions
- 5.3 North America Monoclonal Antibodies Market Analysis
- 5.3.1 North America Monoclonal Antibodies Production
- 5.3.2 North America Monoclonal Antibodies Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Monoclonal Antibodies Import and Export
- 5.4 Europe Monoclonal Antibodies Market Analysis
- 5.4.1 Europe Monoclonal Antibodies Production
- 5.4.2 Europe Monoclonal Antibodies Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Monoclonal Antibodies Import and Export
- 5.5 China Monoclonal Antibodies Market Analysis
- 5.5.1 China Monoclonal Antibodies Production
- 5.5.2 China Monoclonal Antibodies Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Monoclonal Antibodies Import and Export
- 5.6 Japan Monoclonal Antibodies Market Analysis
- 5.6.1 Japan Monoclonal Antibodies Production
- 5.6.2 Japan Monoclonal Antibodies Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Monoclonal Antibodies Import and Export
- 5.7 Southeast Asia Monoclonal Antibodies Market Analysis
- 5.7.1 Southeast Asia Monoclonal Antibodies Production
- 5.7.2 Southeast Asia Monoclonal Antibodies Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Monoclonal Antibodies Import and Export
- 5.8 India Monoclonal Antibodies Market Analysis
- 5.8.1 India Monoclonal Antibodies Production
- 5.8.2 India Monoclonal Antibodies Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Monoclonal Antibodies Import and Export
6 Monoclonal Antibodies Segment Market Analysis (by Type)
- 6.1 Global Monoclonal Antibodies Production by Type
- 6.2 Global Monoclonal Antibodies Revenue by Type
- 6.3 Monoclonal Antibodies Price by Type
7 Monoclonal Antibodies Segment Market Analysis (by Application)
- 7.1 Global Monoclonal Antibodies Consumption by Application
- 7.2 Global Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
8 Monoclonal Antibodies Major Manufacturers Analysis
- 8.1 AbbVie
- 8.1.1 AbbVie Monoclonal Antibodies Production Sites and Area Served
- 8.1.2 AbbVie Product Introduction, Application and Specification
- 8.1.3 AbbVie Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Roche
- 8.2.1 Roche Monoclonal Antibodies Production Sites and Area Served
- 8.2.2 Roche Product Introduction, Application and Specification
- 8.2.3 Roche Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Monoclonal Antibodies Production Sites and Area Served
- 8.3.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.3.3 Johnson & Johnson Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Amgen
- 8.4.1 Amgen Monoclonal Antibodies Production Sites and Area Served
- 8.4.2 Amgen Product Introduction, Application and Specification
- 8.4.3 Amgen Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Merck
- 8.5.1 Merck Monoclonal Antibodies Production Sites and Area Served
- 8.5.2 Merck Product Introduction, Application and Specification
- 8.5.3 Merck Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 BMS
- 8.6.1 BMS Monoclonal Antibodies Production Sites and Area Served
- 8.6.2 BMS Product Introduction, Application and Specification
- 8.6.3 BMS Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Eli Lilly
- 8.7.1 Eli Lilly Monoclonal Antibodies Production Sites and Area Served
- 8.7.2 Eli Lilly Product Introduction, Application and Specification
- 8.7.3 Eli Lilly Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Formation Biologics
- 8.8.1 Formation Biologics Monoclonal Antibodies Production Sites and Area Served
- 8.8.2 Formation Biologics Product Introduction, Application and Specification
- 8.8.3 Formation Biologics Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genmab
- 8.9.1 Genmab Monoclonal Antibodies Production Sites and Area Served
- 8.9.2 Genmab Product Introduction, Application and Specification
- 8.9.3 Genmab Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 GlaxoSmithKline
- 8.10.1 GlaxoSmithKline Monoclonal Antibodies Production Sites and Area Served
- 8.10.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.10.3 GlaxoSmithKline Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Human Genome Sciences
- 8.12 mmunogen
- 8.13 MedImmune
- 8.14 Novartis
- 8.15 Pfizer
- 8.16 Seattle Genetics
- 8.17 Stemcentrx
- 8.18 Synthon Biopharmaceuticals
- 8.19 Takeda
- 8.20 Teva
9 Development Trend of Analysis of Monoclonal Antibodies Market
- 9.1 Global Monoclonal Antibodies Market Trend Analysis
- 9.1.1 Global Monoclonal Antibodies Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Monoclonal Antibodies Regional Market Trend
- 9.2.1 North America Monoclonal Antibodies Forecast 2019-2025
- 9.2.2 Europe Monoclonal Antibodies Forecast 2019-2025
- 9.2.3 China Monoclonal Antibodies Forecast 2019-2025
- 9.2.4 Japan Monoclonal Antibodies Forecast 2019-2025
- 9.2.5 Southeast Asia Monoclonal Antibodies Forecast 2019-2025
- 9.2.6 India Monoclonal Antibodies Forecast 2019-2025
- 9.3 Monoclonal Antibodies Market Trend (Product Type)
- 9.4 Monoclonal Antibodies Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Monoclonal Antibodies Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Monoclonal Antibodies. Industry analysis & Market Report on Monoclonal Antibodies is a syndicated market report, published as Global Monoclonal Antibodies Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Monoclonal Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
